Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals Inc
WKN: A2JQTJ / Symbol: CRNX / Name: Crinetics Pharmaceuticals / Aktie / Small Cap /
45,00 €
-4,27 %
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its price target raised by analysts at Oppenheimer Holdings Inc. from $54.00 to $55.00. They now have an "outperform" rating on the stock.
Ratings data for CRNX provided by MarketBeat
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its price target raised by analysts at Piper Sandler from $56.00 to $97.00. They now have an "overweight" rating on the stock.
Ratings data for CRNX provided by MarketBeat
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
Ratings data for CRNX provided by MarketBeat
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.
Ratings data for CRNX provided by MarketBeat
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
Ratings data for CRNX provided by MarketBeat
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its price target raised by analysts at Morgan Stanley from $50.00 to $70.00. They now have an "overweight" rating on the stock.
Ratings data for CRNX provided by MarketBeat
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its price target raised by analysts at Robert W. Baird from $52.00 to $62.00. They now have an "outperform" rating on the stock.
Ratings data for CRNX provided by MarketBeat
Neueste Beiträge
BWS_Financial in Immersion Corp. diskutieren